To study the effects of FOXO3a activation in drug resistant breast cancer cells, we used a MDA-MB-231 cell line harbouring an expression vector that encodes the hormone binding domain of estrogen receptor α (ERα) fused to the constitutively active FOXO3a(A3). This evidence concerns the gene FOXO3 and breast carcinoma.